Patent · US Active

Imidazolidine derivatives

US8063088B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Henrietta Dehmlow · Weil am Rhein, DE
Ulrike Obst Sander · Sursee, CH
Tanja Schulz-Gasch · Ziefen, CH
Matthew Wright · Basel, CH

Key dates

Filing date	Jun 4, 2009
Grant date	Nov 22, 2011
Priority date	—
Expiry date	Sep 21, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is concerned with novel imidazolidine derivatives of formula (I)wherein R1 to R3, A, D and E are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.